Previous Close | 6.20 |
Open | 6.30 |
Bid | 4.90 |
Ask | 8.50 |
Strike | 30.00 |
Expire Date | 2024-06-21 |
Day's Range | 6.20 - 6.30 |
Contract Range | N/A |
Volume | |
Open Interest | 5 |
On June 3, 2024, Julie Hambleton, Director at SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 4,648 shares of the company.
Badreddin Edris, the Chief Operating Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 20,000 shares of the company on June 3, 2024, according to a recent SEC filing.
On June 3, 2024, Saqib Islam, the Chief Executive Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), executed a sale of 49,000 shares of the company.